Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
98.7M
-
Number of holders
-
201
-
Total 13F shares, excl. options
-
153M
-
Shares change
-
+11.7M
-
Total reported value, excl. options
-
$4.99B
-
Value change
-
+$335M
-
Put/Call ratio
-
1.7
-
Number of buys
-
101
-
Number of sells
-
-106
-
Price
-
$32.68
Significant Holders of GoodRx Holdings, Inc. - Common Stock (GDRX) as of Q4 2021
287 filings reported holding GDRX - GoodRx Holdings, Inc. - Common Stock as of Q4 2021.
GoodRx Holdings, Inc. - Common Stock (GDRX) has 201 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 153M shares
.
Largest 10 shareholders include Francisco Partners Management, LP (84.7M shares), MORGAN STANLEY (12.9M shares), Abdiel Capital Advisors, LP (8.06M shares), VANGUARD GROUP INC (6.05M shares), WELLINGTON MANAGEMENT GROUP LLP (3.86M shares), Silver Lake Group, L.L.C. (3.53M shares), TIGER GLOBAL MANAGEMENT LLC (2.35M shares), GOLDMAN SACHS GROUP INC (1.94M shares), Carmignac Gestion (1.83M shares), and Technology Crossover Management X, Ltd. (1.65M shares).
This table shows the top 201 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.